This work is licensed under the Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License.
Walne AJ, Marrone A, Dokal I: Dyskeratosis congenita: a disorder of defective telomere maintenance? Int J Hematol 2005; 82:184–189.WalneAJMarroneADokalIDyskeratosis congenita: a disorder of defective telomere maintenance?20058218418910.1532/IJH97.0506716207588Search in Google Scholar
Dokal I. Dyskeratosis congenita in all its forms. Br J Haematol. 2000; 110: 768–779.DokalIDyskeratosis congenita in all its forms200011076877910.1046/j.1365-2141.2000.02109.x11054058Search in Google Scholar
Bessler M, Wilson DB, Mason PJ. Dyskeratosis congenita. FEBS Lett. 2010; 584: 3831–3838.BesslerMWilsonDBMasonPJDyskeratosis congenita20105843831383810.1016/j.febslet.2010.05.019323845120493861Search in Google Scholar
Ballew BJ, Savage SA. Updates on the biology and management of dyskeratosis congenita and related telomere biology disorders. Expert Rev Hematol. 2013; 6: 327–37.BallewBJSavageSAUpdates on the biology and management of dyskeratosis congenita and related telomere biology disorders201363273710.1586/ehm.13.2323782086Search in Google Scholar
Alter BP, Giri N, Savage SA, Rosenberg PS. Cancer in dyskeratosis congenita. Blood. 2009; 113(26): 6549–57.AlterBPGiriNSavageSARosenbergPSCancer in dyskeratosis congenita20091132665495710.1182/blood-2008-12-192880271091519282459Search in Google Scholar
Heiss NS, Knight SW, Vulliamy T, SM Klauck, S Wiemann, P J Mason et al. X-linked dyskeratosis congenita is caused by mutations in a highly conserved gene with putative nucleolar functions. Nat Genet. 1998; 19: 32–38.HeissNSKnightSWVulliamyTKlauckSMWiemannSMasonP JX-linked dyskeratosis congenita is caused by mutations in a highly conserved gene with putative nucleolar functions199819323810.1038/ng0598-329590285Search in Google Scholar
Walne AJ, Dokal I: Advances in the understanding of dyskeratosis congenita. Br J Haematol. 2009; 145: 164–172.WalneAJDokalIAdvances in the understanding of dyskeratosis congenita200914516417210.1111/j.1365-2141.2009.07598.x288222919208095Search in Google Scholar
Savage SA, Giri N, Baerlocher GM, Orr N, Lansdorp PM, Alter BP: TINF2, a component of the shelterin telomere protection complex, is mutated in dyskeratosis congenita. Am J Hum Genet. 2008; 82: 501–509.SavageSAGiriNBaerlocherGMOrrNLansdorpPMAlterBPTINF2, a component of the shelterin telomere protection complex, is mutated in dyskeratosis congenita20088250150910.1016/j.ajhg.2007.10.004242722218252230Search in Google Scholar
Calado RT (ed): Progress in Molecular Biology and Translational Science, ed 1. Waltham, Academic Press, 2014.CaladoRT(ed):ed 1.WalthamAcademic Press2014Search in Google Scholar
Du HY, Mason PJ, Bessler M, and Wilson DB. Pediatr. Blood Cancer. 2009; 52: 687.DuHYMasonPJBesslerMWilsonDBPediatr20095268710.1002/pbc.21903286079219090550Search in Google Scholar
Tsangaris E, Adams SL, Yoon G, Chitayat D, Lansdorp P, Dokal I, and Dror Y. Hum. Genet. 2008; 124: 507–513.TsangarisEAdamsSLYoonGChitayatDLansdorpPDokalIDrorY200812450751310.1007/s00439-008-0576-718979121Search in Google Scholar
Walne AJ, Vulliamy T, Beswick R, Michael K, Dokal I. TINF2 mutations result in very short telomeres: analysis of a large cohort of patients with dyskeratosis congenita and related bone marrow failure syndromes. Blood. 2008; 112(9): 3594–3600.WalneAJVulliamyTBeswickRMichaelKDokalITINF2 mutations result in very short telomeres: analysis of a large cohort of patients with dyskeratosis congenita and related bone marrow failure syndromes200811293594360010.1182/blood-2008-05-153445257278818669893Search in Google Scholar
Sarper N, Zengin E, Kilic SC. A child with severe form of dyskeratosis congenita and TINF2 mutation of shelterin complex. Pediatr Blood Cancer. 2010; 55(6):1185–1186.SarperNZenginEKilicSCA child with severe form of dyskeratosis congenita and TINF2 mutation of shelterin complex20105561185118610.1002/pbc.2262420979174Search in Google Scholar
Fukuhara A, Tanino Y, Ishii T, Inokoshi Y, Saito K, Fukuhara N et al. Pulmonary fibrosis in dyskeratosis congenita with TINF2 gene mutation. Eur Respir J. 2013; 42: 1757–1759.FukuharaATaninoYIshiiTInokoshiYSaitoKFukuharaNPulmonary fibrosis in dyskeratosis congenita with TINF2 gene mutation2013421757175910.1183/09031936.0014911324072216Search in Google Scholar
Savage SA. Dyskeratosis Congenita. 2009 Nov 12 [updated 2019 Nov 21]. In: Adam MP, Ardinger HH, Pagon RA, Wallace SE, Bean LJH, Mirzaa G, Amemiya A, editors. GeneReviews® [Internet]. Seattle (WA): University of Washington, Seattle; 1993–2021. Available from http://www.ncbi.nlm.nih.gov/books/NBK22301/ Citation on PubMedSavageSA2009Nov12[updated 2019 Nov 21]. In: Adam MP, Ardinger HH, Pagon RA, Wallace SE, Bean LJH, Mirzaa G, Amemiya A, editors. GeneReviews® [Internet]. Seattle (WA): University of Washington, Seattle; 1993–2021. Available from http://www.ncbi.nlm.nih.gov/books/NBK22301/ Citation on PubMedSearch in Google Scholar
Karremann M, Neumaier-Probst E, Schlichtenbrede F, Beier F, Brümmendorf TH, et al. Revesz syndrome revisited. Orphanet J Rare Dis. 2020; 15: 299.KarremannMNeumaier-ProbstESchlichtenbredeFBeierFBrümmendorfTHRevesz syndrome revisited20201529910.1186/s13023-020-01553-y758328733097095Search in Google Scholar
Hongchun D, Yubiao G, Di M, Kejing T, Decheng C, et al. A case report of heterozygous TINF2 gene mutation associated with pulmonary fibrosis in a patient with dyskeratosis congenita. Medicine (Baltimore). 2018; 97(19): e0724.HongchunDYubiaoGDiMKejingTDechengCA case report of heterozygous TINF2 gene mutation associated with pulmonary fibrosis in a patient with dyskeratosis congenita20189719e072410.1097/MD.0000000000010724595942329742735Search in Google Scholar
Vulliamy T, Beswick R, Kirwan MJ, Hossain U, Walne AJ, and Dokal I. Telomere length measurement can distinguish pathogenic from non-pathogenic variants in the shelterin component, TINF2. Clin Genet. 2012; 81(1): 76–81.VulliamyTBeswickRKirwanMJHossainUWalneAJDokalITelomere length measurement can distinguish pathogenic from non-pathogenic variants in the shelterin component, TINF22012811768110.1111/j.1399-0004.2010.01605.x365417121199492Search in Google Scholar
Sasa GS, Ribes-Zamora A. Nelson ND, Bertuch AA. Three novel truncating TINF2 mutations causing severe dyskeratosis congenita in early childhood. Clin Genet. 2012; 81(5): 470–8.SasaGSRibes-ZamoraANelsonNDBertuchAAThree novel truncating TINF2 mutations causing severe dyskeratosis congenita in early childhood2012815470810.1111/j.1399-0004.2011.01658.x384487021477109Search in Google Scholar
Gutierrez-Rodrigues F, Donaires FS, Pinto A, Vicente A, Dillon LW et al. Pathogenic TERT promoter variants in telomere diseases. Genet Med. 2019; 21(7): 1594–1602.Gutierrez-RodriguesFDonairesFSPintoAVicenteADillonLWPathogenic TERT promoter variants in telomere diseases20192171594160210.1038/s41436-018-0385-x655570030523342Search in Google Scholar
Yang D, He Q, Kim H, Ma W, Songyang Z. TIN2 protein dyskeratosis congenita missense mutants are defective in association with telomerase. J Biol Chem. 2011; 286 (26): 23022–30.YangDHeQKimHMaWSongyangZTIN2 protein dyskeratosis congenita missense mutants are defective in association with telomerase201128626230223010.1074/jbc.M111.225870312307021536674Search in Google Scholar
Li F, Li W, Qiao X, Xie X. Clinical features of dyskeratosis congenita in mainland China: case reports and literature review. Int J Hematol. 2019; 109(3): 328–335.LiFLiWQiaoXXieXClinical features of dyskeratosis congenita in mainland China: case reports and literature review2019109332833510.1007/s12185-018-02582-x30604317Search in Google Scholar
Pereboeva L, Hubbard M, Goldman FD, Westin ER. Robust DNA Damage Response and Elevated Reactive Oxygen Species in TINF2-Mutated Dyskeratosis Congenita Cells. PLoS One. 2016; 11(2): e0148793.PereboevaLHubbardMGoldmanFDWestinERRobust DNA Damage Response and Elevated Reactive Oxygen Species in TINF2-Mutated Dyskeratosis Congenita Cells2016112e014879310.1371/journal.pone.0148793474751026859482Search in Google Scholar
Nelson ND, Dodson LM, Escudero L, Sukumar AT, Williams CL, Mihalek I, et al. The C-Terminal Extension Unique to the Long Isoform of the Shelterin Component TIN2 Enhances Its Interaction with TRF2 in a Phosphorylation and Dyskeratosis Congenita Cluster-Dependent Fashion. Mol Cell Biol. 2018; 38(12): e00025–18.NelsonNDDodsonLMEscuderoLSukumarATWilliamsCLMihalekIThe C-Terminal Extension Unique to the Long Isoform of the Shelterin Component TIN2 Enhances Its Interaction with TRF2 in a Phosphorylation and Dyskeratosis Congenita Cluster-Dependent Fashion20183812e000251810.1128/MCB.00025-18597443129581185Search in Google Scholar
Norberg A, Rosén A, Raaschou-Jensen K, Kjeldsen L, Moilanen JS, Paulsson-Karlsson Y, et al. Novel variants in Nordic patients referred for genetic testing of telomere-related disorders. Eur J Hum Genet. 2018; 26(6): 858–867.NorbergARosénARaaschou-JensenKKjeldsenLMoilanenJSPaulsson-KarlssonYNovel variants in Nordic patients referred for genetic testing of telomere-related disorders201826685886710.1038/s41431-018-0112-8597439329483670Search in Google Scholar
Moussa K, Huang JN, Moore AT. Revesz syndrome masquerading as traumatic retinal detachment. J AAPOS. 2017; 21(5): 422–425.MoussaKHuangJNMooreATRevesz syndrome masquerading as traumatic retinal detachment201721542242510.1016/j.jaapos.2017.04.01628866069Search in Google Scholar
Monoi A, Sugawa M, Kato M, Seki M, Yoshida K, Shiraishi Y, et al. Atypical dyskeratosis congenita diagnosed using whole-exome sequencing. Pediatr Int. 2017; 59(8): 933–935.MonoiASugawaMKatoMSekiMYoshidaKShiraishiYAtypical dyskeratosis congenita diagnosed using whole-exome sequencing201759893393510.1111/ped.1331428643950Search in Google Scholar
Guidugli L, Johnson AK, Alkorta-Aranburu G, Nelakuditi V, Arndt K, Churpek JE, L at all. A Godley, D Townsley, N S Young, C Fitzpatrick, D Del Gaudio, S Das 1, Z Li 1. Clinical utility of gene panel-based testing for hereditary myelodysplastic syndrome/acute leukemia predisposition syndromes. Leukemia. 2017; 31(5): 1226–1229.GuidugliLJohnsonAKAlkorta-AranburuGNelakuditiVArndtKChurpekJEL at all.GodleyATownsleyDYoungN SFitzpatrickCDel GaudioDDasSLiZClinical utility of gene panel-based testing for hereditary myelodysplastic syndrome/acute leukemia predisposition syndromes20173151226122910.1038/leu.2017.28542079028104920Search in Google Scholar
Tomcikova D, Gerinec A, Busanyova B, Gresikova M, Biskup S, Kortnagel K. Why is it necessary to examine retina when the patient suffers from aplastic anemia? Bratisl Lek Listy. 2018;119(5): 275–277.TomcikovaDGerinecABusanyovaBGresikovaMBiskupSKortnagelKWhy is it necessary to examine retina when the patient suffers from aplastic anemia?2018119527527710.4149/BLL_2018_05129749240Search in Google Scholar